Clinical trials
Completed Phase 4 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
611 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 6 |
| 2003 | 24 |
| 2004 | 18 |
| 2005 | 26 |
| 2006 | 34 |
| 2007 | 40 |
| 2008 | 39 |
| 2009 | 37 |
| 2010 | 41 |
| 2011 | 50 |
| 2012 | 43 |
| 2013 | 42 |
| 2014 | 39 |
| 2015 | 32 |
| 2016 | 29 |
| 2017 | 22 |
| 2018 | 20 |
| 2019 | 15 |
| 2020 | 9 |
| 2021 | 11 |
| 2022 | 9 |
| 2023 | 8 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 611 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo | 59 |
| Federal University of São Paulo | 36 |
| Sanofi | 28 |
| University of Campinas, Brazil | 24 |
| University of Sao Paulo General Hospital | 24 |
| Hoffmann-La Roche | 22 |
| Pfizer | 20 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 15 |
| Eli Lilly and Company | 12 |
| Federal University of Minas Gerais | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 34 |
| Pain | 22 |
| Diabetes Mellitus | 18 |
| Hypertension | 18 |
| HIV Infections | 16 |
| Postoperative Pain | 15 |
| Coronary Artery Disease | 11 |
| Pulmonary Disease, Chronic Obstructive | 11 |
| Arthritis, Rheumatoid | 9 |
| Schizophrenia | 9 |
Trials
Showing 1 to 25 of 611. Each trial links to its page on Pharma Observatory.
511 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.